Summary: H.R.2889 — 115th Congress (2017-2018)All Information (Except Text)

There is one summary for H.R.2889. Bill summaries are authored by CRS.

Shown Here:
Introduced in House (06/13/2017)

Closing Loopholes for Orphan Drugs Act

This bill amends the Public Health Service Act to revise the 340B Drug Pricing Program, which currently requires drug manufacturers to discount orphan drugs (drugs for rare conditions) for certain entities covered by the program. The bill discounts orphan drugs that are not being used to treat rare conditions for all entities covered by the program.